Informazioni
Non ci sono recensioni
Punto di Riferimento
per Medici e Operatori Sanitari
per Medici e Operatori Sanitari
LIBRERIA STUDIUM
Chronic Viral Hepatitis
Shetty, Wu
Editore
Springer
Anno
2009
Pagine
503
ISBN
9781934115817
100,00 €
- Provides a concise, well illustrated guide to all aspects of chronic viral hepatitis, including diagnostic and therapeutic algorithms
- Includes recommendations and indications for requesting GI subspecialty consultations
- Each chapter lists "key points" and a summary of the most relevant and practical information related to each topic
- Offers a comprehensive discussion of all aspects of viral hepatitis, including influence of genotype, viral load, ethnicity, co-morbidities, and host immune status
Chronic viral hepatitis affect hundreds of millions of people worldwide, and each year millions more people become infected. In Chronic Viral Hepatitis, Second Edition, a panel of distinguished clinicians and clinical investigators build upon the first edition by comprehensively reviewing all the relevant new information regarding resistance, side effects, and therapies for chronic viral hepatitis. The text covers recent advances in the understanding of pathogenesis of viral hepatitis while discussing promising agents in development for its treatment. The authors devote special attention to reactivation of hepatitis B with chemotherapy and immunosuppression, herbal and non-traditional therapies, chronic viral hepatitis in the pediatric population, and immunology and immunotherapy of HCV and provide relative costs for all diagnostic and therapeutic options. Authoritative and up-to-date, Chronic Viral Hepatitis, Second Edition offers today's gastroenterologists, internists, hepatologists, and infectious disease specialists a practical guide to the recognition, diagnosis and treatment of chronic viral hepatitis from a multidisciplinary approach.
CONTENTS
Preface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vii
Contributors . . . . . . . . . . . . . . . . . . . . . . . . . . . . xi
Molecular Virology of Hepatitis B and C: Clinical Implications . . . 1
Marcy Coash and George Y. Wu
Epidemiology, Risk Factors, and Natural History of Chronic
Hepatitis C . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
Nalini K. Sharma and Averell H. Sherker
Current and Future Therapy of Chronic Hepatitis C . . . . . . . . 71
Mohammad Ashfaq and Gary Davis
Hepatitis C in Special Populations . . . . . . . . . . . . . . . . . 97
Douglas Dieterich, Marie-Louise Vachon
and Damaris Carriero
Extrahepatic Manifestations of Chronic Hepatitis C Infection . . . . 135
Douglas Meyer and Henry C. Bodenheimer Jr.
Anti-HCV Agents in Development . . . . . . . . . . . . . . . . . . 159
Ketan Kulkarni and Ira M. Jacobson
Epidemiology, Screening, and Natural History of Chronic
Hepatitis B Infection . . . . . . . . . . . . . . . . . . . . . . . 185
Shiv K. Sarin and Manoj Kumar
Current Treatment of Chronic Hepatitis B . . . . . . . . . . . . . 243
Walid S. Ayoub and Emmet B. Keeffe
Management of Patients Co-Infected with Chronic
Hepatitis B (CHB) and the Human Immunodeficiency
Virus (HIV) . . . . . . . . . . . . . . . . . . . . . . . . . . . 259
Edward Doo and Marc Ghany
Management of Antiviral Resistance in Chronic Hepatitis B . . . . . 273
Edward Doo and Marc Ghany
ix
x Contents
Herbal and Non-Traditional Therapies for Viral Hepatitis . . . . . . 289
Veronika Gagovic and Paul Kwo
Hepatitis B Reactivation in the Setting of Chemotherapy
and Immunosuppression . . . . . . . . . . . . . . . . . . . . . 307
Halim Charbel and James H. Lewis
Support of Patients During Antiviral Therapy
for Hepatitis B and C . . . . . . . . . . . . . . . . . . . . . . 337
Alyson N. Fox and Thomas W. Faust
Viral Hepatitis, A Through E, In Pregnancy . . . . . . . . . . . . 353
Eashen Liu and Jacqueline Laurin
Chronic Viral Hepatitis and Liver Transplantation . . . . . . . . . 375
Kirti Shetty
Treatment of Viral Hepatitis in Children – 2008 . . . . . . . . . . . 405
Zachary R. Schneider and Parvathi Mohan
Viral Hepatitis and Hepatocellular Carcinoma . . . . . . . . . . . 431
Jorge A. Marrero
Hepatitis B Vaccines . . . . . . . . . . . . . . . . . . . . . . . . 449
Oren Shibolet and Daniel Shouval
T-Cell-Mediated Immunity and Immunotherapy of Chronic
Hepatitis C . . . . . . . . . . . . . . . . . . . . . . . . . . . . 471
Richard C. Duke, Alex Franzusoff and David Apelian
Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 491
